• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Microbiol Biotechnol . Genetic Optimization of Early 2009 Pandemic H1N1 Vaccine Strains for Improved Replication in Embryonated Chicken Eggs

tetano

Editor, Senior Moderator
J Microbiol Biotechnol


. 2025 Dec 15:35:e2510027.
doi: 10.4014/jmb.2510.10027. Genetic Optimization of Early 2009 Pandemic H1N1 Vaccine Strains for Improved Replication in Embryonated Chicken Eggs

Seung-Eun Son[SUP] 1 [/SUP], Jin-Ha Song[SUP] 1 [/SUP], Se-Hee An[SUP] 2 [/SUP], Chung-Young Lee[SUP] 3 [/SUP], Il-Hwan Kim[SUP] 4 [/SUP], Ho-Won Kim[SUP] 1 [/SUP], Kang-Seuk Choi[SUP] 1 5 [/SUP], Hyuk-Joon Kwon[SUP] 5 6 7 8 [/SUP]



Affiliations
Free article Abstract

The 2009 pandemic H1N1 (pdm09) virus is both zoonotic and reverse-zoonotic, transmitting from swine to humans and vice versa. During the early zoonotic phase, immediately after the species jump and before substantial antigenic drift had accumulated, recombinant vaccine strains bearing hemagglutinin (HA) and neuraminidase (NA) from early pdm09 viruses often replicated poorly in embryonated chicken eggs (ECEs), contributing to delays and shortages in vaccine supply. Developing seed strains that are more productive in ECEs while preserving antigenicity and minimizing mammalian pathogenic potential is therefore essential for future pandemic preparedness. Efficient egg replication requires a balanced activity between HA and NA and their coordinated interaction with the polymerase subunit PB2. To this end, we generated PR8-derived recombinants combining PB2 backbones with distinct polymerase activities with targeted HA and NA modifications and edits to segment-specific 3' and 5' noncoding regions (NCRs). Comparative analysis of viral titers, together with sequence-based predictions of mutation effects, identified genotypes that improved replication in eggs while minimizing antigenic variations and reducing markers associated with mammalian virulence. Although further enhancement of viral yield is still warranted, these results delineate practical design principles, favoring balanced tuning of HA-NA functions, PB2 compatibility, and NCR context over large receptor-shift mutations, for engineering influenza seed strains. This work provides actionable guidance to support vaccine development and strengthen One-Health-oriented pandemic preparedness.

Keywords: Influenza A virus; One Health; RNA-dependent RNA polymerase; pandemic H1N1; untranslated regions.

 
Back
Top Bottom